Recently, former U.S. President Donald Trump joked during a public event that a friend of his had taken popular weight-loss medications—such as semaglutide—but saw no results. ‘He took that stuff, but he doesn’t look any thinner—probably because he eats too much!’ Trump quipped. The remark quickly drew media and public attention.While seemingly lighthearted, Trump’s comment reflects broader societal fascination—and controversy—surrounding GLP-1-based weight-loss drugs like Wegovy and Ozempic. Originally developed for diabetes treatment, these medications have surged in popularity due to their significant weight-reduction effects, leading to global shortages. However, their efficacy varies widely among individuals, depending on factors like metabolism, diet, and lifestyle.Health experts emphasize that such medications are not miracle cures; they work best when combined with healthy eating and regular exercise. Trump’s humorous observation subtly underscores this reality, reminding the public that relying solely on pills without changing habits rarely leads to sustainable weight loss. His comment may also serve to deflect speculation about his own health—rumors have previously circulated that he might be using similar drugs to manage his weight.Overall, this offhand joke not only reveals how celebrities engage with trending health topics but also highlights common misconceptions about quick-fix weight-loss solutions.
近日，美国前总统唐纳德·特朗普在一次公开活动中调侃其一位朋友服用热门减肥药物（如司美格鲁肽）却未见成效。他表示：‘他吃了那种药，但看起来一点都没瘦——可能是因为他吃得太多了！’此番言论迅速引发媒体和公众关注。特朗普的评论表面上看似玩笑，实则折射出当前社会对GLP-1类减肥药物（如Wegovy、Ozempic）的高度关注与争议。这类药物原本用于治疗糖尿病，近年因其显著减重效果而风靡全球，甚至出现供不应求的情况。然而，并非所有人都能从中受益，其效果受个体代谢、饮食习惯及生活方式等多重因素影响。专家指出，减肥药并非“万能灵丹”，必须配合健康饮食与规律运动才能发挥最佳效果。特朗普以幽默方式点出这一现实，也间接提醒公众：依赖药物而不改变生活习惯，很难实现持久减重。此外，他的发言也可能意在淡化外界对其本人健康状况的猜测——此前有传言称他可能使用类似药物控制体重。总体而言，这则调侃既反映了名人对流行健康趋势的态度，也揭示了公众对快速减肥方法的期待与误解。
原创文章，作者：admin，如若转载，请注明出处：https://avine.cn/16624.html